Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
Browse the world's most comprehensive archive of hedge fund manager letters. Access primary source research from leading institutional managers, sorted by reporting period.
Moon Capital outlines how long-term corporate earnings compounding triumphed over alarming 2025 headlines, and highlights a new contrarian investment in Molina Healthcare (MOH) as a highly mispriced compounder.
Full Quick Take
Moon Capital outlines how long-term corporate earnings compounding triumphed over alarming 2025 headlines, and highlights a new contrarian investment in Molina Healthcare (MOH) as a highly mispriced compounder.
